SITUATION OF ESCHERICHIA COLI’S β LACTAMASE PRODUCTION AND VALUE OF DETECTING METHODS
Main Article Content
Abstract
Background: Currently, Escherichia coli's extended spectrum β-lactamase production is a major concern for infectious diseases in Vietnam as well as in the world. Understanding about detection of extended spectrum β-lactamase production is very necessary. Objectives: To determine the proportion of Escherichia coli's extended spectrum β-lactamase production by the combined disk method and the phoenix M50 automatic machine; To determine the sensitivity and specificity values of the combined disk method and the phoenix M50 automatic machine for detecting extended spectrum β-lactamase-producing. Materials and method: A cross-sectional descriptive study on 155 Escherichia coli strains collected from clinical specimens of infected patients at Can Tho Central General Hospital from 7/2021-5/2022. Extended spectrum β-lactamase was detected by the combined disk test method and using the phoenix M50 automatic machine. Results: The proportion of Escherichia coli's extended spectrum β-lactamase production is 60.7% with the combined plate method and 58.9% with the Phoenix M50 automatic machine. The extended spectrum β-lactamase production assay by the combined plate method has a sensitivity and specificity of 99.1% and 98.6%, respectively. Using Phoenix M50, the sensitivity and specificity are 86.3% and 84.2%, respectively. The almost complete compatibility between the two methods of Escherichia coli's extended spectrum β-lactamase production with kappa coefficient is 0.989. Conclusion: The proportion of Escherichia coli's extended spectrum β-lactamase production by the combined plate method and the Phoenix M50 machine is quite high and the compatibility between the two methods is almost complete (kappa=0.989). Thus, the combination plate method should be recommended because of its higher efficiency.
Article Details
Keywords
Escherichia coli, ESBL, combined disk, Phoenix M50
References
2. Mai Thị Thu Huyền, Nguyễn Đình Duy, Nguyễn Hữu Lân (2018), “Các vi khuẩn thường gặp và tính đề kháng kháng sinh của chúng tại Bệnh viện Phạm Ngọc Thạch từ 11/2016 – 11/2017”, Tạp chí Y học Thành Phố Hồ Chí Minh, 22(5), tr. 196-200.
3. Lương Hồng Loan, Huỳnh Minh Tuấn (2020), “Trực khuẩn gram âm tiết ESBL và phổ đề kháng kháng sinh tại Bệnh viện Y học TP. Hồ Chí Minh”, 24(2), tr. 223-229.
4. Nguyễn Thành Tín (2018), “Xác định kiểu hình và kiểu gen của vi khuẩn Escherichia coli và Klebsiella pnemoniae tiết ESBL phân lập tại Bệnh viện Đa khoa Bạc Liêu”, Tạp chí Y học Thành phố Hồ Chí Minh, số 5, tr. 246-251.
5. Chakraborty A., Adhikari P., Shenoy S. & Saralaya V. (2015), “Clinical significance and phylogenetic background of extended spectrum beta-lactamase producing Escherichia coli isolates from extra-intestinal infections”, J Infect Public Health, 8(3), pp. 248-253.
6. Chang Y.T., Coombs G., Ling T., et al. (2017), “Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013”, Int J Antimicrob Agents, 49(6), pp. 734-739.
7. Drieux L, Brossier F, Sougakoff W. and Jarlier V. (2010), “Phenotypic detection of extended – spectrum beta-lactamase producing in Enterobacteriaceae”. CMI, 14(Suppl.1), pp. 90-103.
8. WHO ( 2019), “New report calls for urgent action to avert antimicrobial resistance crisis”, Joint News Release, pp.1-4.